Baywater Healthcare Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Baywater Healthcare Limited - overview
Established
2006
Location
Crewe, Cheshire, UK
Primary Industry
Medical Devices & Equipment
About
Based in the UK, Baywater Healthcare Limited focuses on providing home oxygen therapy and associated healthcare services to enhance the quality of life for patients with chronic respiratory conditions. Baywater Healthcare Limited operates in the healthcare sector, specializing in home oxygen therapy. The company is headquartered in Crewe, UK. In December 2017, Bastide Le Confort Medical acquired Baywater Healthcare, although financial terms were not disclosed.
The company has a total of three deals, with the most recent deal occurring on December 13, 2017. Baywater Healthcare specializes in providing home oxygen therapy and a range of associated healthcare services aimed at patients with long-term conditions. Their core offerings include Home Oxygen Therapy, managed telehealth services, virtual wards, nebuliser therapy, home ventilation therapy, and recovery oxygen services. These services are designed to enhance the quality of life for individuals suffering from chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), emphysema, and obstructive sleep apnoea.
Baywater Healthcare's products are utilized primarily within the UK healthcare system, serving over 40,000 patients nationwide, including home oxygen patients, healthcare professionals, and carers. The company has been integral to the NHS Home Oxygen Service since its inception in 2006, contributing to a patient-centric model that facilitates care closer to home. In 2023, Baywater Healthcare achieved a revenue of USD 40. 45 mn, with an EBITDA of USD 8.
89 mn. The company generates revenue through its direct provision of healthcare services and products primarily on a subscription basis, catering to both consumers and healthcare institutions. Clients include hospitals, hospices, and individual patients requiring long-term oxygen therapy, engaging through a helpline and online clinician portal for service requests and order management. Baywater Healthcare aims to expand its product offerings and services in the coming years.
The company is exploring new technologies and methods to enhance its home oxygen therapy solutions. Additionally, there are plans for geographical expansion into new markets, although specific regions and dates have yet to be finalized. The recent acquisition by Bastide Le Confort Medical may provide additional resources to support these growth initiatives.
Current Investors
Tikehau Investment Management, Bastide Le Confort Medical
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices, Medical Supplies, Diagnostic Equipment
Website
www.baywater.co.uk
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Baywater Healthcare Limited - timeline of key events
Baywater Healthcare Limited - financials
| Fiscal Year Ended | Sep 30, 2014 | Sep 30, 2015 | Sep 30, 2016 | Sep 30, 2017 | Sep 30, 2018 | Sep 30, 2019 | Jun 30, 2020 | Jun 30, 2021 | Jun 30, 2022 | Jun 30, 2023 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 17,286,000 | 21,327,000 | 22,511,000 | 23,252,000 | 24,251,000 | 25,675,000 | 21,075,000 | 27,997,000 | - | - | - |
| % Revenue Growth (YoY) | - | 23.4% | 5.6% | 3.3% | 4.3% | 5.9% | - | - | - | - | - |
| EBITDA (USD) | 6,611,000 | 12,481,000 | 8,774,000 | 9,443,000 | 9,091,000 | 10,048,000 | 6,418,000 | 6,056,000 | - | - | - |
| Operating Income (USD) | 2,721,000 | 6,335,000 | 4,570,000 | 5,416,000 | 4,981,000 | 6,104,000 | 3,232,000 | 1,231,000 | - | - | - |
| Operating Margin | 15.7% | 29.7% | 20.3% | 23.3% | 20.5% | 23.8% | 15.3% | 4.4% | - | - | - |
| % EBITDA Margin | 38.2% | 58.5% | 39.0% | 40.6% | 37.5% | 39.1% | 30.5% | 21.6% | - | - | - |
| NET Income (USD) | 1,857,000 | 5,030,000 | 4,170,000 | 4,752,000 | 4,055,000 | 5,050,000 | 2,593,000 | 710,000 | - | - | - |
| % Net Margin | 10.7% | 23.6% | 18.5% | 20.4% | 16.7% | 19.7% | 12.3% | 2.5% | - | - | - |
Baywater Healthcare Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Baywater Healthcare Limited | - | ||||||||
| Trade Sale | Completed | Baywater Healthcare Limited | - | ||||||||
| Buyout | Completed | Baywater Healthcare Limited | - |
Displaying 1 - 3 of 3
Baywater Healthcare Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.